Prevalence and risk factors for the presence of serum cryoglobulins in patients with chronic hepatitis C

Journal of Viral Hepatitis

Volumn 7, Issue 2, 2000, Pages 138-143

  Cicardi, ^a,b   Cesana, ^b   Del, N ^a,b   Pappalardo, ^a,b   Silini, ^c   Agostoni, ^a,b   Colombo, ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^c Associazione Studi Avanzati Epatite Virale   (Italy)

Author keywords

B lymphocytes; Cirrhosis; Complement; Cryoglobulins; HCV genotype; Rheumatoid factor

Indexed keywords

CHOLINESTERASE; COMPLEMENT COMPONENT C3; CRYOGLOBULIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; RHEUMATOID FACTOR; VIRUS RNA;

ADULT; AGED; ARTICLE; CRYOGLOBULINEMIA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS C; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR;

ADULT; AGED; BIOLOGICAL MARKERS; CRYOGLOBULINS; FEMALE; HEPATITIS C, CHRONIC; HUMANS; ITALY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREVALENCE; RISK FACTORS;

EID: 0034108710     PISSN: 13520504     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2893.2000.00204.x     Document Type: Article

References (24)

1. 1 Sansonno D, De Vita S, Iacobelli AR, Cornacchiulo V, Boiocchi M, Dammacco F. Clonal analysis of intrahepatic B cells from HCV-infected patients with and without mixed cryoglobulinemia. J Immunol 1998; 160: 3594-3601.
2. 2 Andreone P, Zignego AL, Cursaro C et al. Prevalence of monoclonal gammopathies in patients with hepatitis C virus infection. Ann Intern Med 1998; 129: 294-298.
3. 3 Lunel F, Musset L, Cacoub P et al. Cryoglobulinemia in chronic liver diseases: role of hepatitis C virus and liver damage. Gastroenterology 1994; 106: 1291-1300.
4. 4 Wong VS, Egner W, Elsey T et al. Incidence, character and clinical relevance of mixed cryoglobulinemia in patients with chronic hepatitis C virus infection. Clin Exp Immunol 1996; 104: 25-31.
5. 5 Adinolfi LE, Utili R, Attanasio V et al. Epidemiology, clinical spectrum and prognostic value of mixed cryoglobulinemia in hepatitis C virus patients: a prospective study. Ital J Gastroenterol 1996; 28: 1-9.
6. 6 Agnello V, Abel G. Localization of hepatitis C virus in cutaneous vasculitic lesions in patients with type II cryoglobulinemia. Arthritis Rheum 1997; 40: 2007-2015.
7. 7 Misiani R, Bellavita PM, Fenili D et al. Interferon alpha-2a therapy in cryoglobulinemia associated with hepatitis C virus. N Engl J Med 1994; 330: 751-756.
8. 8 Shimizu YK, Iwamoto A, Hijikata M, Purcell RH, Yoshikura H. Evidence for in vitro replication of hepatitis C virus genome in a human T-cell line. Proc Natl Acad Sci USA 1992; 89: 5477-5481.
9. 9 Shimizu YK, Feinstone SM, Kohara M, Purcell RH, Yoshikura H. Hepatitis C virus detection in intracellular virus particles by electron microscopy. Hepatology 1996; 23: 205-209.
10. 10 Sansonno D, Iacobelli AR, Cornacchiulo V, Iodice G, Dammacco F. Detection of hepatitis C virus (HCV) proteins by immunofluorescence and HCV RNA genomic sequences by non-isotopic in situ hybridization in bone marrow and peripheral blood mononuclear cells of chronically HCV-infected patients, Clin Exp Immunol 1996; 103: 414-421.
11. 11 Sansonno D, De Vita S, Cornacchiulo V, Carbone A, Boiocchi M, Dammacco F. Detection and distribution of C virus-related protein in lymph nodes of patients with type II mixed cryoglobulinemia and neoplastic or non-neoplastic lymphoproliferation. Blood 1996; 88: 4638-4645.
12. 12 Mazzaro C, Franzin F, Tulissi P et al. Regression of monoclonal B-cell expansion in patients affected by mixed cryoglobulinemia responsive to a-interferon therapy. Cancer 1996; 77: 2604-2613.
13. 13 Santagostino E, Colombo M, Cultraro D, Muça-Perja M, Gringeri A, Mannucci PM. High prevalence of serum cryoglobulinemia in multitransfused hemophilic patients with chronic hepatitis C. Blood 1998; 92: 516-519.
14. 14 Silini EM, Bono F, Cividini A et al. Differential distribution of hepatitis C virus genotypes in patients with and without liver function abnormalities. Hepatology 1995; 21: 285-290.
15. 15 Okamoto H, Sugiyama Y, Okada S et al. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources. J Gen Virol 1992; 73: 673-679.
16. 16 Okamoto H, Tokita H, Sakamoto M et al. Characterization of genomic sequence of type V (or 3a) hepatitis C virus isolates and PCR primers for specific detection. J Gen Virol 1993; 74: 2385-2390.
17. 17 Musset L, Diemert MC, Taibi F et al. Characterization of cryoglobulins by immunoblotting. Clin Chem 1992; 38: 798-802.
18. 18 Brouet JC. Clauvel JP. Danon F, Klein M, Seligmann M. Biologic and clinical significance of cryoglobulins. Am J Med 1974; 57: 775-788.
19. 19 Ahmed SA, Penhale WJ, Talal IN. Sex hormones, immune response and autoimmune disease. Am J Pathol 1992; 121: 431-438.
20. 20 Agnello V. Hepatitis C virus infection and type II cryoglobulinemia: an immunological perspective. Hepatology 1997; 26: 1375-1379.
21. 21 De Vita S, Sacco C, Sansonno D et al. Characterization of overt B-cell lymphomas in patients with hepatitis C virus infection. Blood 1997; 90: 776-782.
22. 22 Zignego AL, Ferri C, Giannini C et al. Hepatitis C virus genotype analysis in patients with type II mixed cryoglobulinemia. Ann Intern Med 1996; 124: 31-34.
23. 23 Frangeul L, Musset L, Cresta P, Cacoub P, Hurax JM, Lunel F. Hepatitis C virus genotypes and subtypes in patients with hepatitis C, with and without cryoglobulinemia. J Hepatol 1996; 25: 427-432.
24. 24 Pawlotsky JM, Roudot-Thoraval F, Simmonds P et al. Extrahepatic immunologic manifestations in chronic hepatitis C virus serotypes. Ann Intern Med 1995; 122: 169-173.